You are here

  • Home
  • Archive
  • Volume 102, Issue 2
  • Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye

Article metrics

Article menu
Download PDFPDF
Clinical science
Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye

 

Online download statistics by month:

Online download statistics by month: June 2017 to September 2024

AbstractFullPdf
Jun 20172561610
Jul 20175624430
Aug 20171642118
Sep 201712251
Oct 2017293288
Nov 2017159166
Dec 2017112255
Jan 20183454923
Feb 20184304816
Mar 20181774317
Apr 2018116288
May 2018137265
Jun 2018152339
Jul 201884314
Aug 2018121293
Sep 201893314
Oct 201890162
Nov 201894151
Dec 201860175
Jan 201958163
Feb 2019107174
Mar 20194775
Apr 20194622
May 201946102
Jun 201961162
Jul 201945144
Aug 201945152
Sep 201942173
Oct 201966132
Nov 201939130
Dec 201950161
Jan 202054150
Feb 202088200
Mar 202079213
Apr 202078232
May 202069262
Jun 202063171
Jul 202069194
Aug 202032161
Sep 202056181
Oct 202072181
Nov 20204710
Dec 20208933
Jan 20218400
Feb 20215612
Mar 20218121
Apr 20213421
May 20211411
Jun 2021323
Jul 2021313
Aug 2021200
Sep 2021111
Oct 20213300
Nov 20213500
Dec 20212023
Jan 20223821
Feb 20225022
Mar 20223822
Apr 20223900
May 20225921
Jun 20225620
Jul 20223200
Aug 20226450
Sep 20225521
Oct 20227073
Nov 20223221
Dec 20222400
Jan 20232533
Feb 20236100
Mar 20233651
Apr 2023910
May 20235300
Jun 20233910
Jul 20233910
Aug 20233131
Sep 20231000
Oct 20234621
Nov 20234310
Dec 20232400
Jan 20243801
Feb 2024711
Mar 20243033
Apr 20242213
May 20242900
Jun 20247320
Jul 20244510
Aug 20246700
Sep 20246033
Total6725940266